RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Remogliflozin Etabonate in the Treatment of Type 2 Diabetes: Design, Development, and Place in Therapy.

Remogliflozin Etabonate in the Treatment of Type 2 Diabetes: Design, Development, and Place in Therapy.

Add to Collection
2020 Others V Mohan, A Mithal, SR Joshi, SR Aravind… - … and Therapy, 2020 - Taylor & Francis

Full Author : ['Mohan, Viswanathan', 'Mithal, Ambrish', 'Joshi, Shashank R', 'Aravind, S R', 'Chowdhury, Subhankar']
Journal Title : Drug design, development and therapy
Chapter : Section3
Journal Year : 2020
Cited by : 23.0

Type 2 diabetes mellitus (T2DM) is an emerging epidemic in Asian countries, especially in India. With the advent of the SGLT2 inhibitor class of drugs demonstrating benefits beyond glycemic control, viz. weight loss, blood pressure reduction, and cardiova..... Read More

Keywords : ["type diabetes design development", "remogliflozin etabonate", "treatment", "therapy", "place"]
PubMed Link : https://www.tandfonline.com/doi/abs/10.2147/DDDT.S221093
Google Scholar Link : https://scholar.google.com/scholar?cites=8475253551751943899&as_sdt=5,41&sciodt=0,41&hl=en&num=20